NAVIGATE GRX Study

NCT04883008 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-12-20

No results posted yet for this study

Summary

The objective of the present study is to detail the results of robotic-assisted PCI using technIQ automated movements in real-world clinical practice.

Conditions

Interventions

DEVICE

CorPath GRX with technIQ automated movements enabled (technIQ ON)

The CorPath GRX System is intended for use in the remote delivery and manipulation of guidewires and rapid exchange catheters, and remote manipulation of guide catheters during percutaneous coronary and vascular procedures. TechnIQ automated movements are software-based automation of common maneuvers that interventionalists perform when manipulating catheters, guidewires, and devices by hand. In this group, automated movements will be enabled and used at the discretion of the interventionalist.

DEVICE

CorPath GRX with technIQ automated movements disabled (technIQ OFF).

The CorPath GRX System is intended for use in the remote delivery and manipulation of guidewires and rapid exchange catheters, and remote manipulation of guide catheters during percutaneous coronary and vascular procedures. TechnIQ automated movements are software-based automation of common maneuvers that interventionalists perform when manipulating catheters, guidewires, and devices by hand. In this group, automated movements will be disabled.

Sponsors & Collaborators

  • Corindus Inc.

    lead INDUSTRY

Principal Investigators

  • Jean Fajadet, MD · Groupe Cardiovasculaire Interventionnel, Clinique Pasteur

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-14
Primary Completion
2022-02-04
Completion
2022-02-07
FDA Device
Yes

Countries

  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04883008 on ClinicalTrials.gov